Oramed (ORMP) CEO donates 100,000 shares to charity

Rhea-AI Filing Summary

ORAMED PHARMACEUTICALS INC. President and CEO Nadav Kidron reported a bona fide charitable gift of 100,000 shares of Common Stock on March 12, 2026. The filing states this was a charitable donation, not a market transaction, and no value was received for the shares.

Following the donation, Kidron directly holds 3,255,238 shares of Oramed common stock. The footnote further explains that he is not affiliated with, and has no control over, the charitable donee, underscoring that this is a non-economic transfer rather than a sale in the open market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIDRON NADAV

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS, THIRD FLOOR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORAMED PHARMACEUTICALS INC. [ ORMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		G(1)		100,000	D	$0	3,255,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction represents a charitable donation and is not a market transaction, thus no price has been reported. No value was received for the donated shares. The Reporting Person is not affiliated with, and has no control over, the donee.

	/s/ Nadav Kidron	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Oramed (ORMP) report for Nadav Kidron?

Oramed reported that CEO Nadav Kidron made a bona fide charitable gift of 100,000 shares of common stock. The transfer was classified as a non-market transaction, with no price reported and no value received for the donated shares.

Was the Oramed (ORMP) CEO’s 100,000-share transfer a sale?

The 100,000-share transfer was not a sale; it was a charitable donation. The filing states it is not a market transaction, no price was reported, and no value was received, distinguishing it from an open-market disposition.

How many Oramed (ORMP) shares does Nadav Kidron hold after the donation?

After donating 100,000 shares, Nadav Kidron directly holds 3,255,238 shares of Oramed common stock. This post-transaction figure in the filing helps show that the gifted amount represents a relatively small portion of his overall direct holdings.

Did Oramed’s (ORMP) CEO receive any compensation for the donated shares?

According to the filing footnote, Nadav Kidron received no value for the 100,000 donated shares. It describes the transaction as a charitable donation, not a market trade, and explicitly notes that no consideration or sale proceeds were obtained.

Is the Oramed (ORMP) CEO affiliated with the charity receiving the shares?

The filing states that the reporting person is not affiliated with, and has no control over, the charitable donee. This clarification emphasizes the donation nature of the transaction and that the CEO does not direct or manage the receiving organization.